Sex steroid action in adolescence: Too much, too little; too early, too late

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Standard

Sex steroid action in adolescence : Too much, too little; too early, too late. / Hansen, A. B.; Wøjdemann, D.; Renault, C. H.; Pedersen, A. T.; Main, K. M.; Raket, L. L.; Jensen, R. B.; Juul, A.

I: European Journal of Endocrinology, Bind 184, Nr. 1, 01.2021, s. R17-R28.

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Harvard

Hansen, AB, Wøjdemann, D, Renault, CH, Pedersen, AT, Main, KM, Raket, LL, Jensen, RB & Juul, A 2021, 'Sex steroid action in adolescence: Too much, too little; too early, too late', European Journal of Endocrinology, bind 184, nr. 1, s. R17-R28. https://doi.org/10.1530/EJE-20-0545

APA

Hansen, A. B., Wøjdemann, D., Renault, C. H., Pedersen, A. T., Main, K. M., Raket, L. L., Jensen, R. B., & Juul, A. (2021). Sex steroid action in adolescence: Too much, too little; too early, too late. European Journal of Endocrinology, 184(1), R17-R28. https://doi.org/10.1530/EJE-20-0545

Vancouver

Hansen AB, Wøjdemann D, Renault CH, Pedersen AT, Main KM, Raket LL o.a. Sex steroid action in adolescence: Too much, too little; too early, too late. European Journal of Endocrinology. 2021 jan.;184(1):R17-R28. https://doi.org/10.1530/EJE-20-0545

Author

Hansen, A. B. ; Wøjdemann, D. ; Renault, C. H. ; Pedersen, A. T. ; Main, K. M. ; Raket, L. L. ; Jensen, R. B. ; Juul, A. / Sex steroid action in adolescence : Too much, too little; too early, too late. I: European Journal of Endocrinology. 2021 ; Bind 184, Nr. 1. s. R17-R28.

Bibtex

@article{557cd1faf1004cb5b1291173f40d60e9,
title = "Sex steroid action in adolescence: Too much, too little; too early, too late",
abstract = "This review aims to cover the subject of sex steroid action in adolescence. It will include situations with too little sex steroid action, as seen in for example, Turners syndrome and androgen insensitivity issues, too much sex steroid action as seen in adolescent PCOS, CAH and gynecomastia, too late sex steroid action as seen in constitutional delay of growth and puberty and too early sex steroid action as seen in precocious puberty. This review will cover the etiology, the signs and symptoms which the clinician should be attentive to, important differential diagnoses to know and be able to distinguish, long-term health and social consequences of these hormonal disorders and the course of action with regards to medical treatment in the pediatric endocrinological department and for the general practitioner. This review also covers situations with exogenous sex steroid application for therapeutic purposes in the adolescent and young adult. This includes gender-affirming therapy in the transgender child and hormone treatment of tall statured children. It gives some background information of the cause of treatment, the patient's motivation for medicating (or self-medicating), long-term consequences of exogenous sex steroid treatment and clinical outcome of this treatment.",
author = "Hansen, {A. B.} and D. W{\o}jdemann and Renault, {C. H.} and Pedersen, {A. T.} and Main, {K. M.} and Raket, {L. L.} and Jensen, {R. B.} and A. Juul",
note = "Publisher Copyright: {\textcopyright} 2021 European Society of Endocrinology Printed in Great Britain",
year = "2021",
month = jan,
doi = "10.1530/EJE-20-0545",
language = "English",
volume = "184",
pages = "R17--R28",
journal = "European Journal of Endocrinology",
issn = "0804-4643",
publisher = "BioScientifica Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - Sex steroid action in adolescence

T2 - Too much, too little; too early, too late

AU - Hansen, A. B.

AU - Wøjdemann, D.

AU - Renault, C. H.

AU - Pedersen, A. T.

AU - Main, K. M.

AU - Raket, L. L.

AU - Jensen, R. B.

AU - Juul, A.

N1 - Publisher Copyright: © 2021 European Society of Endocrinology Printed in Great Britain

PY - 2021/1

Y1 - 2021/1

N2 - This review aims to cover the subject of sex steroid action in adolescence. It will include situations with too little sex steroid action, as seen in for example, Turners syndrome and androgen insensitivity issues, too much sex steroid action as seen in adolescent PCOS, CAH and gynecomastia, too late sex steroid action as seen in constitutional delay of growth and puberty and too early sex steroid action as seen in precocious puberty. This review will cover the etiology, the signs and symptoms which the clinician should be attentive to, important differential diagnoses to know and be able to distinguish, long-term health and social consequences of these hormonal disorders and the course of action with regards to medical treatment in the pediatric endocrinological department and for the general practitioner. This review also covers situations with exogenous sex steroid application for therapeutic purposes in the adolescent and young adult. This includes gender-affirming therapy in the transgender child and hormone treatment of tall statured children. It gives some background information of the cause of treatment, the patient's motivation for medicating (or self-medicating), long-term consequences of exogenous sex steroid treatment and clinical outcome of this treatment.

AB - This review aims to cover the subject of sex steroid action in adolescence. It will include situations with too little sex steroid action, as seen in for example, Turners syndrome and androgen insensitivity issues, too much sex steroid action as seen in adolescent PCOS, CAH and gynecomastia, too late sex steroid action as seen in constitutional delay of growth and puberty and too early sex steroid action as seen in precocious puberty. This review will cover the etiology, the signs and symptoms which the clinician should be attentive to, important differential diagnoses to know and be able to distinguish, long-term health and social consequences of these hormonal disorders and the course of action with regards to medical treatment in the pediatric endocrinological department and for the general practitioner. This review also covers situations with exogenous sex steroid application for therapeutic purposes in the adolescent and young adult. This includes gender-affirming therapy in the transgender child and hormone treatment of tall statured children. It gives some background information of the cause of treatment, the patient's motivation for medicating (or self-medicating), long-term consequences of exogenous sex steroid treatment and clinical outcome of this treatment.

U2 - 10.1530/EJE-20-0545

DO - 10.1530/EJE-20-0545

M3 - Review

C2 - 33112274

AN - SCOPUS:85096080018

VL - 184

SP - R17-R28

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

SN - 0804-4643

IS - 1

ER -

ID: 282195417